Latest News in Cancer
Stay updated with the most recent articles and resources.
Main Topics
Treosulfan with fludarabine is approved by the USFDA as a preparative regimen for alloHSCT in adult and pediatric patients with AML or MDS
The FDA approved the **treosulfan and fludarabine** preparative regimen for **allogeneic hematopoietic stem cell transplantation (alloHSCT)** in adult and pediatric patients with acute myeloid leukemia...
Fam-trastuzumab deruxtecan-nxki is approved by the USFDA for unresectable or metastatic HR-positive, HER2-low or HER2-ultralow breast cancer
On January 27, 2025, the Food and Drug Administration sanctioned fam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi Sankyo, Inc.) for unresectable or metastatic hormone receptor (HR)-positive, HER2-low (IHC...
Datopotamab deruxtecan-dlnk is approved by the USFDA for unresectable or metastatic, HR-positive, HER2-negative breast cancer
The FDA has approved datopotamab deruxtecan (Dato-DXd) to treat unresectable or metastatic HR-positive, HER2-negative breast cancer following previous endocrine treatment and chemotherapy. The drug treats...
Sotorasib with panitumumab is approved by the USFDA for KRAS G12C-mutated colorectal cancer
The FDA has also approved the combination of sotorasib and panitumumab to treat KRAS G12C-mutated colorectal cancer that advanced on previous treatments. This represents a...
Acalabrutinib with bendamustine and rituximab is approved by the USFDA for previously untreated mantle cell lymphoma
The FDA has approved the combination of acalabrutinib, bendamustine, and rituximab for previously untreated mantle cell lymphoma (MCL). This regimen provides a new first-line treatment...
Encorafenib with cetuximab and mFOLFOX6 is approved by the USFDA for metastatic colorectal cancer with a BRAF V600E mutation
The FDA has granted accelerated approval for the combination of encorafenib, cetuximab, and mFOLFOX6 for treating metastatic colorectal cancer (mCRC) with a BRAF V600E mutation....
Remestemcel-L-rknd is approved by the USFDA for steroid-refractory acute graft versus host disease in pediatric patients
The FDA has approved Remestemcel-L (Ryoncil, remestemcel-L-rknd) in pediatric patients with steroid-refractory acute graft-versus-host disease (SR-aGVHD). The allogeneic mesenchymal stromal cell therapy is a new...
Comparing Deceased Donor vs. Living Donor Liver Transplants: Pros and Cons
Liver transplant Liver transplant is a lifesaving surgery for patients with end-stage liver disease, acute liver failure, or some genetic liver diseases. The liver...
Nutritional Advice for Liver Transplant Patients: Pre-and Post-Surgery
Liver transplantation is a sophisticated procedure, and nutrition plays an important role both in pre-transplant preparation and post-transplant recovery. Patients should emphasize keeping protein levels...
Immunotherapy for bladder cancer
Immunotherapy is revolutionizing bladder cancer treatment by harnessing the immune system to fight cancer cells. Checkpoint inhibitors like pembrolizumab and nivolumab have shown promising results...
The Psychological Impact of Liver Transplantation on Patients and Families
Liver transplantation is a lifesaving operation, but it comes with huge psychological burdens on patients and their loved ones. From pre-transplant worry to postoperative depression,...
Advances in Liver Transplant Surgery: Techniques and Technologies
Liver transplant surgery has come a long way with advances in minimally invasive procedures, organ preservation, and artificial intelligence. Advances in laparoscopic donor hepatectomy, normothermic...
Need help? Our team is ready to assist you.
We wish a speedy recovery for your loved ones.